Organon & Co. (OGN)
NYSE: OGN
· Real-Time Price · USD
9.53
0.38 (4.15%)
At close: May 29, 2025, 3:59 PM
9.26
-2.83%
After-hours: May 29, 2025, 07:56 PM EDT
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|
| Asia Pacific And Japan Revenue | 1.05B | 1.13B | 1.14B | 1.17B |
| Asia Pacific And Japan Revenue Growth | -7.00% | -1.22% | -2.56% | n/a |
| China Revenue | 847M | 864M | 917M | 933M |
| China Revenue Growth | -1.97% | -5.78% | -1.71% | n/a |
| Europe And Canada Revenue | 1.76B | 154M | 151M | 233M |
| Europe And Canada Revenue Growth | +1044.81% | +1.99% | -35.19% | n/a |
| Latin America, Middle East, Russia And Africa Revenue | 1.03B | 1.48B | n/a | n/a |
| Latin America, Middle East, Russia And Africa Revenue Growth | -30.04% | n/a | n/a | n/a |
| Other Countries Revenue | 137M | n/a | n/a | n/a |
| Other Countries Revenue Growth | n/a | n/a | n/a | n/a |
| United States Revenue | 1.57B | n/a | n/a | n/a |
| United States Revenue Growth | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 420M | 470M | 422M | 437M | 431M | 469M | 538M | 451M | 435M | 470M | 440M | 423M | 371M | 481M | 388M | 416M | 382M | 744M | 321M | 284M | 317M |
| Selling, General, and Administrative Revenue Growth | -10.64% | +11.37% | -3.43% | +1.39% | -8.10% | -12.83% | +19.29% | +3.68% | -7.45% | +6.82% | +4.02% | +14.02% | -22.87% | +23.97% | -6.73% | +8.90% | -48.66% | +131.78% | +13.03% | -10.41% | n/a |
| Research and Development Revenue | 96M | 130M | 111M | 116M | 112M | 134M | 137M | 128M | 129M | 142M | 127M | 106M | 96M | 189M | 111M | 76M | 67M | 154M | 54M | 51M | 45M |
| Research and Development Revenue Growth | -26.15% | +17.12% | -4.31% | +3.57% | -16.42% | -2.19% | +7.03% | -0.78% | -9.15% | +11.81% | +19.81% | +10.42% | -49.21% | +70.27% | +46.05% | +13.43% | -56.49% | +185.19% | +5.88% | +13.33% | n/a |